Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Temozolomide in Metastatic Uveal Melanoma
NCT01217398Phase 2Unknown
- Sponsor
- Institut Curie
- Start
- Oct 2009
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Uveal melanoma (UM), sponsored by Institut Curie. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT01217398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217398.